The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
According to AbbVie's latest financial reports and stock price the company's current Operating Margin is 25.56%. At the end of 2021 the company had an Operating Margin of 23.11%.
Year | Operating Margin | Change |
---|---|---|
2021 | 23.11% | 211.56% |
2020 | 7.42% | -70.71% |
2019 | 25.33% | 59.63% |
2018 | 15.87% | -42.06% |
2017 | 27.39% | -10.95% |
2016 | 30.75% | 5.79% |
2015 | 29.07% | 144.93% |
2014 | 11.87% | -58.17% |
2013 | 28.38% | -8.9% |
2012 | 31.15% | 48.11% |
2011 | 21.03% | -31.99% |
2010 | 30.92% | -26.13% |
2009 | 41.86% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | 29.90% | -99.90% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 22.40% | -99.58% | ๐บ๐ธ USA |
![]() Amgen AMGN | 29.35% | -99.80% | ๐บ๐ธ USA |
![]() Biogen BIIB | 32.74% | -99.84% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 16.73% | -99.85% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 16.50% | -99.87% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | -0.70% | -99.83% | ๐ฌ๐ง UK |
![]() GlaxoSmithKline GSK | 15.36% | -99.93% | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | 8.94% | -99.71% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.